The TNM staging system and breast cancer

被引：44

作者：

Benson, JR ^{[1
]}

机构：

[1] Addenbrookes Hosp, Cambridge Breast Unit, Cambridge, England

来源：

LANCET ONCOLOGY | 2003年 / 4卷 / 01期

关键词：

D O I：

10.1016/S1470-2045(03)00961-6

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：56 / 57

页数：2

共 26 条

[1]

Abe O, 1998, LANCET, V352, P930

[2] TIME TO ABANDON TNM STAGING OF BREAST-CANCER [J].

BARR, LC ;

BAUM, M .

LANCET, 1992, 339 (8798) :915-917

[3]

Bedrosian I., 1999, Breast Cancer Research and Treatment, V57, P35

[4] TIME OUT FOR TNM [J].

BENSON, JR .

LANCET, 1992, 339 (8803) :1234-1234

[5]

CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO

[6]

2-H

[7] Role of immunohistochemical detection of lymph-node metastases in management of breast cancer [J].

Cote, RJ ;

Peterson, HF ;

Chaiwun, B ;

Gelber, RD ;

Goldhirsch, A ;

Castiglione-Gertsch, M ;

Gusterson, B ;

Neville, AM .

LANCET, 1999, 354 (9182) :896-900

[8] Ipsilateral local recurrence of breast cancer: determinant or indicator of poor prognosis? [J].

della Rovere, GQ ;

Benson, JR .

LANCET ONCOLOGY, 2002, 3 (03) :183-187

[9]

DELLAROVERE GQ, 2001, CANCER, V89, P707

[10]

Denoix PF, 1944, B I NAT HYG PARIS, V1, P1

← 1 2 3 →